Clinical Trial Update: Phase Ib/II Trial of coPANlisib in Combination With Trastuzumab in HER2-positive Breast Cancer. (Panther Study) [Phase 1]

View source ↗

Summary

This document reports a completed Phase Ib/II study evaluating copanlisib in combination with trastuzumab for HER2-positive breast cancer (Panther study).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Aliqopa (copanlisib)
• HERCEPTIN (trastuzumab)

Snippet

Sponsor: Cancer Trials Ireland | Conditions: HER2 Positive Breast Cancer | Phase 1 | Status: COMPLETED